
Sign up to save your podcasts
Or


By The Wall Street Journal & Spotify Studios
4.2
56105,610 ratings
The podcast currently has 1,854 episodes available.
The most played episodes among Podcast App listeners.

The U.S. and Canada are once again embroiled in a fight over tariffs. During negotiations last week, President Trump threatened big hikes. Canada retaliated with their own tariffs. WSJ’s Gavin Bade explains how trade negotiations between two countries broke down and what could come next. Ryan Knutson hosts. Further Listening: - Tariffs Are Back. What’s Changed? - Canada’s New Leader Is Ready To Take on Trump Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

America is using less cardboard, which is bad news for the farmers who grow the pulpwood trees that get turned into paper products. WSJ’s Ryan Dezember explains how the cheapest, smallest trees in the forest hold up a much larger timber industry. Ryan Knutson hosts. Further Listening: - The Bean at the Center of the Trade War - Is Jane Goodall Fighting a Losing Battle? Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

For decades, food companies have relied on a proven playbook: cater to shoppers with sugar, salt and flavor. This approach has been so successful that some critics have accused the food industry of fueling an obesity epidemic. But with weight-loss drugs and health-conscious shopping on the rise, food companies have a whole new challenge. WSJ’s Amira McKee explores the new ways food makers are meeting the moment. Jessica Mendoza hosts. Further Listening: - Trillion Dollar Shot - Weight-Loss Drugs Are Gobbling Up Small Town Budgets Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

President Trump called it “the biggest oil deal in world history.” After months of secretive negotiations there was a surprise announcement that the U.S. government was getting a direct stake in a private oil company in Venezuela. WSJ’s Vera Bergengruen reports on how the deal came together and the challenges facing what’s being billed as a big foreign policy win. Jessica Mendoza hosts. Further Listening: - Oil Companies Aren't Sold on Venezuela - Was Maduro’s Capture About Oil? Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in high-risk patients, sending drug industry stocks soaring. WSJ’s Xavier Martinez traces Moderna’s wild ride from scrappy startup to the frontier of cancer treatment. Ryan Knutson hosts. Further Listening: - The FDA Commissioner on Vaccines and Public Trust - The Creator of the Record-Setting Covid Vaccine Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
The podcast currently has 1,854 episodes available.

30,691 Listeners

2,825 Listeners

1,713 Listeners

4,341 Listeners

1,982 Listeners

1,644 Listeners

111,979 Listeners

674 Listeners

56,469 Listeners

1,426 Listeners

1,039 Listeners

5,226 Listeners

1,559 Listeners

156 Listeners

1,322 Listeners

585 Listeners

151 Listeners

143 Listeners